DMARDs: What Impact Do They Have on COVID-19 Outcomes in RA?
Rheum Advisor on Air
English - June 29, 2021 15:38 - 13 minutes - 18 MBMedicine Health & Fitness health healthcare medicine rheumatology Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Psoriasis and Psoriatic Arthritis: Providing Bidirectional Care
Next Episode: The Dish on Diet and Nutrition in Rheumatic Diseases
In the first episode of the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress series, we spoke with co-authors Jeffrey Sparks, MD, and Zachary Wallace, MD, about their research – the association between disease-modifying antirheumatic drug (DMARD) use and COVID-19 outcomes in rheumatoid arthritis (RA) – conducted on behalf of the COVID-19 Global Rheumatology Alliance.
The study was presented by Dr Sparks and Dr Wallace at the EULAR 2021 meeting and has been published in BMJ.